Friday, June 12, 2009

Mesothelioma Trials

Mesothelioma Clinical Trials

Until recently, clinical trials for mesothelioma were difficult to conduct. The disease had a rapid onset and progression, leading to a relatively short survival period in which to conduct clinical trials. Also, there was a lack of basic understanding about the clinical biology of the disease and how the disease changed during progression.

Specific clinical measures were difficult to obtain in order to demonstrate the response to treatment. Recently, as part of the Alimta clinical trial, researchers developed new metrics that included factors other than just pleural thickening or abnormal breathing capability. A number of new clinical trials are now underway, many of them using these new measurement techniques. Hopefully these trials will lead to ways to stop or reverse the progression of mesothelioma.

Mesothelioma Trial Phases

Clinical trials for evaluating mesothelioma treatments are broken into four parts or phases. These Phases are described below (Source FDA).

Phase I
Researchers evaluate a drug or treatment in a small group of people/patients (20 to 80) for the first time to evaluate a drug's safety, determine the appropriate dosage range and identify side effects.

Phase II
Researchers treat a larger group of people/patients to determine if the drug treatment is effective and safe for the dosage levels determined in Phase I.

Phase III
Researchers administer the drug or treatment to a large group of people/patients to confirm the effectiveness of the drug and evaluate the drug's side effects. In this phase, the drug under evaluation will be compared to commonly used treatments. Additionally, researchers use Phase III trials to determine the proper protocol for the use of the drug when it is released for routine treatment.

Phase IV
Researchers perform follow-up studies from Phase III, primarily to obtain information that can be used when marketing the drug, such as drug risks, benefits and optimum use.

[Page updated March 2006]

Types of Mesothelioma

Mesothelioma cancer affects the serous membranes that surround the major organs in the midsection of the body. Different organs can be affected by mesothelioma because the serous membranes surround the lungs, heart, abdomen and others. The most common type of mesothelioma is that which affects the lung lining, and is called pleural mesothelioma. Other types are pericardial mesothelioma, which affects the lining of the heart, and peritoneal mesothelioma, affecting the lining of the abdomen.

Mesothelioma, contrary to what many people think, is not a type of primary lung cancer. That is, mesothelioma does not originate in the lungs, but as described above, it starts in the serous membranes or lining around the lungs (or other organs). However, mesothelioma can spread to the lungs and when this occurs, it is considered to be a secondary lung cancer. Mesothelioma is also commonly referred to as an asbestos lung cancer. Technically, this is also incorrect, since mesothelioma does not originate in the lungs. Asbestosis is a type of asbestos lung disease that is often confused with mesothelioma.

Pleural Mesothelioma

Pleural mesothelioma represents about 75% of all mesotheliomas. The disease can grow quickly and enlarge the pleural space, causing it to fill with fluid. This fluid leads to the discomfort or pain associated with first detection of the disease. It is thought that pleural mesothelioma is caused by the inhaling of fibrous materials, including asbestos. These fibers lodge in the pleura and, over time, cause damage to the tissue layer and cancer erupts. Learn more about pleural mesothelioma.

Pericardial Mesothelioma

The rarest form of mesothelioma is that which affects the linings of the heart cavity, called the pericardium. Less than 10% of all mesothelioma cases are related to the heart. As in the lung, the rapid growth of the cancerous tumors can cause expansion of the tissue and accumulation of fluid. The fluid can interfere with the functioning of the heart and cause chest pain. Mesothelioma cases are known to be caused by exposure to asbestos; but it is completely unknown how the asbestos fibers enter the tissue layers surrounding the heart. Learn more about pericardial mesothelioma.

Peritoneal Mesothelioma

Mesothelioma of the abdomen is called peritoneal mesothelioma. The serous membrane surrounding the abdomen is known as the peritoneum. This disease accounts for approximately 10% to 20% of mesothelioma cases. In addition, a rare form of peritoneal mesothelioma affects the male testicles. The covering layer of the scrotum is actually an outpouching of the peritoneum. Peritoneal mesothelioma is due to the ingestion of fibrous materials, including asbestos. Learn more about peritoneal mesothelioma.

[Page updated February 2005]

We believe that all asbestos-product manufacturers

About asbestos

We believe that all asbestos-product manufacturers are equally responsible for asbestos-caused injuries and deaths, and we will fight to win justice for their victims. The asbestos lawyers at Trine & Metcalf - located in Boulder, Colorado - stand ready to assist victims of pleural mesothelioma in many states, including Washington, Idaho, Utah, New Mexico, Wyoming, Nebraska, and Montana.

About asbestos

Help from Asbestos Attorneys in Colorado

Asbestos is a naturally occurring, fibrous, harmful mineral that was widely used in the manufacture of many products, beginning in the late nineteenth century. Today we know that when asbestos fibers are inhaled, they become embedded in the lungs and eventually cause life-threatening diseases such as asbestosis, lung cancer, and pleural mesothelioma.

Between 1940 and 1980, thousands of workers in a number of industries were put at high risk for asbestos exposure. This included workers at construction sites, shipyards, and railroads, as well as insulation installers, sheet metal installers, plasterers, drywallers, pipefitters, floor-covering installers, cement installers and finishers, automobile repair workers, and laborers in related fields. Evidence shows that 1) companies that manufactured these asbestos-containing products knew their products would injure people and 2) these companies actively conspired to hide this information so they could keep selling their products. As a result, these companies are now being held liable for the workers' resulting injuries.

We believe that all asbestos-product manufacturers are equally responsible for asbestos-caused injuries and deaths, but these companies have fiercely contested each and every charge-making trials extremely long and repetitive. What's worse, several asbestos product manufacturers filed bankruptcy in the 1980s and 1990s to avoid having to compensate the victims of asbestos disease. The asbestos attorneys at Trine & Metcalf - located in Boulder, Colorado - are determined to bring these companies to justice. Since we filed the first asbestos personal injury lawsuit in 1974, our mesothelioma attorneys have represented hundreds of victims who suffer from asbestos-linked diseases in Colorado, Washington, New Mexico, Wyoming, Montana, Nebraska, and other states throughout the Pacific Northwest. If you or a loved one has developed mesothelioma as a result of asbestos exposure, our attorneys can help you pursue a lawsuit. You may be able to receive compensation to help defray medical costs as well as assist you in your emotional distress. Please contact us today. We assist residents of Colorado, Washington, and the states listed above.

MESOTHELIOMA

What is pleural mesothelioma?


Pleural Mesothelioma is a rare cancer caused by inhalation of asbestos, a naturally occurring yet lethal fiber used in many products and as insulation in older buildings.

Colorado Mesothelioma Lawyers

The Colorado mesothelioma lawyers at Trine & Metcalf have provided the following information on pleural mesothelioma treatments. For further inquiries about our mesothelioma law firm, please contact us today.

Pleural Mesothelioma
Minimal Medical Pleural Mesothelioma Treatment
Aggressive Medical Pleural Mesothelioma Treatment
Alternative Pleural Mesothelioma Treatment
Gene Therapy and Other Experimental Treatments

Pleural Mesothelioma

Pleural Mesothelioma is a rare cancer of the pleura, the thin sac that lines the outer edge of the lungs. The disease is caused by exposure to asbestos, a naturally occurring yet lethal fiber used in many products and as insulation in older buildings. When inhaled, asbestos fibers become embedded in the pleura and cause lesions, scarring, and degeneration. People who work in factories that manufacture asbestos-containing products are at highest risk for developing pleural mesothelioma, for which there is no cure.

Common symptoms of mesothelioma include:

  • Continuous coughing
  • Coughing up blood
  • Abdominal pain
  • Shortness of breath
  • Extreme tiredness or fatigue
  • Chest pain
  • Substantial weight loss

Pleural mesothelioma is often fatal; most people die within two years of diagnosis. However, as more is learned about the disease, new treatments are developed, increasing chances of survival. Some current methods of treatment used to combat the disease include:

  • Minimal Medical Pleural Mesothelioma Treatment
  • Aggressive Medical Pleural Mesothelioma Treatment
  • Alternative Pleural Mesothelioma Treatment
  • Gene Therapy

Back to top

Minimal Medical Pleural Mesothelioma Treatment

The goal of minimal medical pleural mesothelioma treatment is to make both the patient and the patient's family more comfortable. The cancer is not treated with surgery, chemotherapy, or radiation. Instead, minimal treatment involves removing accumulated fluid from the chest - a principal cause for pain and shortness of breath - as well as progressively stronger pain-relieving narcotics, hospice or nursing support, and psychological support from the patient's friends and family.

Removing fluid accumulations from the chest

The accumulation of fluid in the chest is one of the principal causes of pain and shortness of breath in people with mesothelioma. These fluid accumulations (called pleural effusions) are common with mesothelioma. Progressively stronger narcotics are usually prescribed.

Relieving pain

Pain is usually relieved via medication. Progressively stronger narcotics are usually prescribed.

Providing hospice or nursing support

Caring for a loved one who is dying from cancer can be physically and emotionally draining. Professional care assistance can be a great relief for both the patient and the patient's family.

Providing psychological and social support for both the patient and the patient's family

A diagnosis of mesothelioma, as with other forms of deadly cancers, can be very stressful for the patient's loved ones. Professional counselors and support groups can provide important assistance in coping with stresses experienced by the entire family.

To learn more about minimal medical pleural mesothelioma treatment or to speak with our lawyers about a lawsuit, contact our offices in Boulder, Colorado. Also assisting residents of Washington and several other states.

Back to top

Aggressive Medical Pleural Mesothelioma Treatment

Aggressive mesothelioma treatment includes the surgical removal of the entire pleura, the lung on the affected side, the diaphragm, and the pericardium, or any combination of these organs; chemotherapy; and radiation therapy. In many cases, more than one means of treatment may be used.

Surgery

There are several medical centers in the U.S. where thoracic surgeons with special training and facilities perform a major, radical surgery called extrapleural pneumonectomy. During this surgery, the entire pleura (a thin sac surrounding the lung) and lung on the affected side are removed. Frequently, the diaphragm and pericardium (the lining around the heart) on the affected side are also removed. Synthetic materials are then used to reconstruct the diaphragm, primarily to keep the content of the chest separate from the abdomen.

Chemotherapy

There appears to be little evidence that currently available chemotherapeutic agents (by themselves and without accompanying surgery) have any real effect on mesothelioma. Therefore, chemotherapy is usually administered after an extrapleural pneumonectomy. People may have very strong adverse side effects to chemotherapy. However, there are some people who do have, at least for a period, a positive response to chemotherapy.

Radiation

Radiation treatments may also be given as a follow-up treatment to radical surgery. As with chemotherapy, there is little evidence that radiation alone has any real benefit in prolonging life or quality of life in mesothelioma patients. Some people may have significant adverse side effects to radiation treatment.

Factors to consider with these treatments include:

Recuperation and quality of life

Extrapleural pneumonectomy (the surgery for mesothelioma treatment) is serious. Patients who have this surgery sometimes take up to a year to recover from the surgery. Therefore, there are significant quality-of-life issues that a patient should consider before agreeing to this surgery, if the surgery is an available option. In addition, the chemotherapy and radiation treatment administered after the surgery may cause some patients to feel extremely sick while they are receiving treatments.

Availability

The pioneering work in aggressive mesothelioma treatment was performed by a surgeon working in Boston. The treatment is only available in major medical centers and teaching hospitals. Surgeons offering this type of treatment carefully select patients for the treatment. Age, overall health, and extent of spread (the 'stage') of the mesothelioma are factors that surgeons and oncologists evaluate when selecting candidates for the surgery.

Cost

The surgery and follow-up treatments are very expensive. The cost includes fees for the physician, significant periods of hospitalization, chemotherapy, and radiation treatments. If the patient and any family members or friends must travel long distances to reach a facility where the treatment is provided, they incur the additional expenses of airfare, lodging, and related travel expenses. We have seen the medical expenses associated with this type of treatment exceed $150,000. Cost varies depending on where the treatment takes place, but it is always an expensive course of treatment no matter where it is provided. Some patients decline these treatments because of the high cost; pain and discomfort of surgery, chemotherapy and radiation; and the negative impact on the quality of their lives. Other patients feel the treatment is a chance they must take.

To learn more about aggressive medical pleural mesothelioma treatment or to speak with our attorneys about a lawsuit, contact our offices in Boulder, Colorado. Also assisting residents of Washington and several other states.

Back to top

Alternative Pleural Mesothelioma Treatment

There are institutions, such as Oasis Medical Center in Tijuana, Mexico, that offer non-traditional approaches to managing mesothelioma. These alternative programs are administered by physicians and other health care professionals. The alternative approaches may involve use of nutritional supplements and unconventional regimes of medicines. We understand that the Oasis Center in Tijuana does not claim its approach will cure mesothelioma. Instead they believe their treatments may inhibit the growth of the tumor, thereby extending the patient's life without the substantial period of pain and rehabilitation associated with major surgery, chemotherapy, and radiation.

The growth of the mesothelioma in one of our clients appears to have been significantly slowed after receiving treatment provided at the Oasis. We do not know (perhaps no one knows) if the indolent behavior of his mesothelioma is due to the treatment he received from Oasis or other factors.

The cost of alternative treatments is significantly less than that of aggressive medical treatment. However, many medical insurances providers only cover the aggressive medical treatment.

To learn more about alternative medical pleural mesothelioma treatment or to speak with our lawyers about a lawsuit, contact our offices in Boulder, Colorado. Also assisting residents of Washington and several other states.

Back to top

Gene Therapy and Other Experimental Treatments

There may be mesothelioma patients treated with surgery, chemotherapy, and radiation who survived longer than they would have without the treatment. Some patients may have an increase in quality of life as a result of some types of treatment. However, very few mesothelioma patients have been 'cured' as a result of such treatments. ('Cure' is defined as survival more than five years after treatment.) Increasingly, doctors are offering patients experimental treatments to combat their mesothelioma when standard treatments fail. Currently, these include gene therapy, photodynamic therapy, and immunotherapy.

Gene Therapy

Gene therapy is being explored as a possible treatment for mesothelioma. Specially prepared genetic material is injected into the cancer. This genetic material selectively attacks the cancer genes, killing the cancer. Medical scientists at the cutting edge of gene therapy for mesothelioma (such as those at the University of Pennsylvania Medical Center) say gene therapy for mesothelioma is in the experimental stage. They are cautiously optimistic that gene therapy may prove to be a useful tool in treating at least some people with mesothelioma.

Gene therapy for mesothelioma can be used with or without other types of treatment. To date, it has been more frequently employed as a supplement or follow-up to surgery. Surgery is performed to remove the bulk of the tumor. Gene therapy is used in an effort to eliminate the cancer cells that always remain after surgery for mesothelioma.

The cost of gene therapy is significant. Costs for a complete course of gene therapy for mesothelioma can range from $150,000 to $950,000.

Other Experimental Treatments

Other forms of experimental treatment for mesothelioma are photodynamic therapy and immunotherapy. As with gene therapy, these therapies are available only at specific medical centers (usually teaching hospitals engaged in highly specialized medical research).

To learn more about gene therapy and other types of experimental pleural mesothelioma treatment or to speak with our attorneys about a lawsuit, contact our offices in Boulder, Colorado. Also assisting residents of Washington and several other states.

Please note: You should only rely on the advice of your physician when considering treatment options for mesothelioma or any other disease. The above information is a distillation of our own experience with clients diagnosed with mesothelioma, their efforts at getting treatment, interviews with medical and cancer experts, and readings of the current medical literature concerning mesothelioma.

Utah Mesothelioma Lawer and Legal Information

Utah Mesothelioma Lawyer and Legal Information

Currently there are no asbestos personal injury or product liability suits in the Utah trial courts, though there have been suits in the past. This may be surprising since Utah is home to a site that processed vermiculite from the asbestos-contaminated W.R. Grace mine in Libby, Montana. In 2004, the EPA warned that asbestos contamination in the area surrounding the Utah site could possibly put nearby neighbors at risk of asbestos exposure.

Determination of Liability

Utah courts follow a modified comparative liability - 50 percent rule in determining whether to award damages in a case involving asbestos liability. Under the 50 percent modification, a plaintiff can only recover damages if they are found 49 percent or less responsible in causing their own injuries. If the plaintiff is determined to be 50 percent or greater at fault for their own injuries, they recover no damages. In cases where the plaintiff is found to be partly at fault but less than 50 percent at fault in their own injuries, any damages determined by the jury are reduced proportionate to the percentage of fault. In other words, in a case where the plaintiff is determined to be 30 percent at fault and the damages are judged to amount to $100,000, the plaintiff can recover $70,000.

The courts in Utah follow a pure several liability approach in apportioning damages in cases with multiple defendants. Under a pure several liability approach, each defendant is assigned a portion of the fault in causing the plaintiff's injury, and is only responsible for the portion of the damages that correspond to their percentage of the fault. For instance, in a case where damages of $100,000 are awarded, and company A is 25 percent responsible while company B is 75 percent responsible, company A will be responsible for $25,000 of the judgment and company B for $75,000.

Utah allows punitive damages under common law principles.


Utah Asbestos Litigation

The Utah courts have recently made some interesting decisions that affect how asbestos cases are handled in the state, including decisions regarding medical criteria for establishing impairment and punitive damages. Jury verdicts in Utah cases are generally lower than those seen in jurisdictions that have high asbestos trial traffic.

2007 - Carbaugh v. Asbestos Corporation et al: The Supreme Court of the State of Utah heard an appeal from plaintiffs whose case was dismissed on a summary judgment because the doctor who was engaged as an expert witness was not licensed to practice medicine in Utah. The Supreme Court reversed the ruling and allowed the case to go forward, stating that lower court made an error when it determined that the medical expert had practiced medicine without a license in Utah.

1993 - Hansen v. Mountain Fuel Supply Co.: Five workers were exposed to asbestos while working at Mountain Fuel. They filed suit alleging worry and anxiety over future cancer entitled them to damages for negligent infliction of emotional distress. The case was dismissed by a trial court, but reversed upon appeal by the Utah Supreme Court, which stated that individuals bringing an NIED claim must show evidence that their emotional distress was severe along with meeting eight different criteria in order to seek a settlement against a defendant for possible future medical costs.


STATE LAWS

Find state laws, legal codes & legal state statutes.


Friday, June 5, 2009

Mesotheliona Clinical Trials

In order to one day find a mesothelioma cure, doctors engage in clinical trials where they test new mesothelioma drugs to determine the if they are effective.

Mesothelioma clinical trials follow a plan of very strict scientific guidelines, which is called a protocol. The protocol explains everything that will happen in the study. It must be approved by review boards made up of health care professionals and other qualified people before the study can enroll patients.

When a potential mesothelioma drug is first identified, preclinical studies, which are conducted in a laboratory setting, help to find out whether the drug is safe to test in humans. During this stage, the drug is usually studied in animals to answer questions about how a drug works and how the body changes and disposes of it. Humans do not participate in preclinical studies. There are four possible phases of cancer clinical trials in humans, each designed to answer different questions about the treatment being studies.

In Phase I mesothelioma clinical trials, doctors are primarily studying the safety of giving mesothelioma drugs to humans, while also looking for the best way to give a medication (for example, as a pill, an injection, or an infusion). They will usually study how the mesothelioma drug is eliminated from the body in humans. Also, doctors are trying to find the right doses for further testing. They carefully watch for any side effects. Phase I study drugs are usually given to small groups of humans. During this phase, for drugs used to treat mesothelioma cancer, investigators may be able to find out which tumors a treatment works best in.

In Phase II mesothelioma clinical trials, the mesothelioma drug is studies in a larger group. The primary purpose of these studies is to see how well the drug or treatment shrinks tumors in patients with specific types of cancer. The investigator will watch closely for side effects and will also watch how the disease responds to the treatment.

In Phase III mesothelioma clinical trials, the new cancer treatment is generally compared to a standard existing treatment. Patients are usually randomly assigned (that is, a process similar to flipping a coin is used to determine which treatment the patient receives) to receive either a standard treatment or the new treatment. During the trial, patients may or may not be told which treatment they are getting but are told what to expect and what to watch for. Occasionally, even the doctor will not know which treatment each patient is getting so that he or she can remain unbiased about how the disease is responding to the treatment. (This is uncommon in cancer clinical trials). Phase III studies are designed to ensure that any side effects that patients experience are identified treated according to local standards of care.

Phase IV mesothelioma clinical trials study a drug that has already been approved by the Food and Drug Administration. Drug companies often sponsor these trials to study even more uses of drugs already available.



Clinical Trials: Mesothelioma

California

Duarte; City of Hope National Medical Center
A Double-Blind Placebo Controlled Randomized Phase II of Gemcitabine & Cisplatin With Or Without the VEGF Inhibitor Bevacizumab in Patients with Malignant Mesothelioma

San Diego; Sharp Clinical Oncology Research
ONCONASE ® plus doxorubicin vs. doxorubicin for patients with Malignant Pleural or Peritoneal Mesothelioma who have had no more than one prior chemotherapy regimen.

Colorado

Aurora; Research Center
ALIMTA Plus Gemcitabine (Gemzar) for Patients with Malignant Pleural or Peritoneal Mesothelioma who have not had previous chemotherapy

Aurora; University of Colorado Cancer Center
ONCONASE ® plus doxorubicin vs. doxorubicin for patients with Malignant Pleural or Peritoneal Mesothelioma who have had no more than one prior chemotherapy regimen.

Florida

Miami; Oncology / Hematology Group of South Florida
ONCONASE ® plus doxorubicin vs. doxorubicin for patients with Malignant Pleural or Peritoneal Mesothelioma who have had no more than one prior chemotherapy regimen.

Tampa; Research Center
ALIMTA Plus Gemcitabine (Gemzar) for Patients with Malignant Pleural or Peritoneal Mesothelioma who have not had previous chemotherapy

Illinois

Chicago; Research Center
ALIMTA Plus Gemcitabine (Gemzar) for Patients with Malignant Pleural or Peritoneal Mesothelioma who have not had previous chemotherapy

Chicago; University of Chicago Medical Center, Section of Hematology / Oncology
ONCONASE ® plus doxorubicin vs. doxorubicin for patients with Malignant Pleural or Peritoneal Mesothelioma who have had no more than one prior chemotherapy regimen.

Indiana

South Bend; Northern Indiana Cancer Research Consortium
ONCONASE ® plus doxorubicin vs. doxorubicin for patients with Malignant Pleural or Peritoneal Mesothelioma who have had no more than one prior chemotherapy regimen.

Maryland

Baltimore; Research Center
ALIMTA Plus Gemcitabine (Gemzar) for Patients with Malignant Pleural or Peritoneal Mesothelioma who have not had previous chemotherapy

Massachusetts

Boston; Research Center
ALIMTA Plus Gemcitabine (Gemzar) for Patients with Malignant Pleural or Peritoneal Mesothelioma who have not had previous chemotherapy

Michigan

Grand Rapids; Spectrum Health, Cook Research Department
ONCONASE ® plus doxorubicin vs. doxorubicin for patients with Malignant Pleural or Peritoneal Mesothelioma who have had no more than one prior chemotherapy regimen.

New Jersey

Somerville; Somerset Medical Center
ONCONASE ® plus doxorubicin vs. doxorubicin for patients with Malignant Pleural or Peritoneal Mesothelioma who have had no more than one prior chemotherapy regimen.

New Mexico

Albuquerque; Research Center
ALIMTA Plus Gemcitabine (Gemzar) for Patients with Malignant Pleural or Peritoneal Mesothelioma who have not had previous chemotherapy

New York

New York; Columbia-Presbyterian Medical Center
ALIMTA Plus Gemcitabine as Front-Line Chemotherapy for Patients with Malignant Pleural or Peritoneal Mesothelioma. A phase II Clinical Trial.

New York; Columbia-Presbyterian Medical Center
Open - Label Study of Alimta (pemetrexed) Combination with Cisplatin for Chemonaive Patients with Malignant Pleural Mesothelioma.

New York; Research Center
ALIMTA Plus Gemcitabine (Gemzar) for Patients with Malignant Pleural or Peritoneal Mesothelioma who have not had previous chemotherapy

New York; Columbia Presbyterian Medical Center
ONCONASE ® plus doxorubicin vs. doxorubicin for patients with Malignant Pleural or Peritoneal Mesothelioma who have had no more than one prior chemotherapy regimen.

New York; Columbia University Medical Center
A phase II, open-label, non-randomized, multicenter, single agent study of intravenous sdx-102 for the treatment of patients with MTAP - deficient cancers.

New York; Columbia-Presbyterian Medical Center
Phase II trial of combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for treatment of peritoneal mesothelioma.

New York; Columbia-Presbyterian Medical Center
Phase II trial of perioperative gemcitabine and cisplatin chemotherapy in resected pleural mesothelioma

New York; Biomedical Research Alliance of New York
Cancer in the Lungs- Caused by exposure to asbestos

Oklahoma

Tulsa; Southwestern Regional Medical Center
Open-Label Study of ALIMTA (pemetrexed) and Cisplatin in chemonaive patients with malignant Pleural Mesothelioma.

Texas

Austin; Lone Star Oncology Consultants, PA
ONCONASE ® plus doxorubicin vs. doxorubicin for patients with Malignant Pleural or Peritoneal Mesothelioma who have had no more than one prior chemotherapy regimen.

Houston; S. R. Burzynski Clinic
Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Mesothelioma

Wisconsin

Madison; Research Center
ALIMTA Plus Gemcitabine (Gemzar) for Patients with Malignant Pleural or Peritoneal Mesothelioma who have not had previous chemotherapy

International

D-14109 Berlin, Germany; Pneumologie II, Zentralklinik Emil von Bering
ONCONASE ® plus doxorubicin vs. doxorubicin for patients with Malignant Pleural or Peritoneal Mesothelioma who have had no more than one prior chemotherapy regimen.

D-21075 Hamburg, Germany; Allgemeines Krankenhaus Harburg
ONCONASE ® plus doxorubicin vs. doxorubicin for patients with Malignant Pleural or Peritoneal Mesothelioma who have had no more than one prior chemotherapy regimen.

D-22927 Grosshansdorf, Germany; Krankenhaus Grosshansdorf, Zentrum fur Pneumologie und Thoraxchirurgie, Pneumo.- Onkolog. Abteilung
ONCONASE ® plus doxorubicin vs. doxorubicin for patients with Malignant Pleural or Peritoneal Mesothelioma who have had no more than one prior chemotherapy regimen.

D-81675 Munchen, Germany; TU Munchen, Klinikum Rechts der Isar, Med. Klinik Hamatologie und Onkologie
ONCONASE ® plus doxorubicin vs. doxorubicin for patients with Malignant Pleural or Peritoneal Mesothelioma who have had no more than one prior chemotherapy regimen.

D-82131 Gauting, Germany; Asklepios Fachkliniken, Zentrum fur Pneumologie und Thoraxchirurgie
ONCONASE ® plus doxorubicin vs. doxorubicin for patients with Malignant Pleural or Peritoneal Mesothelioma who have had no more than one prior chemotherapy regimen.

Alessandria, Italy; Azienda Osped. Nazion Antonio e Biagio e Cesare Arrigo, Divisione di Pneumologia
ONCONASE ® plus doxorubicin vs. doxorubicin for patients with Malignant Pleural or Peritoneal Mesothelioma who have had no more than one prior chemotherapy regimen.

Genova, Italy; Struttura Semplice di Pneumotisiologia, Ospedale San Marino
ONCONASE ® plus doxorubicin vs. doxorubicin for patients with Malignant Pleural or Peritoneal Mesothelioma who have had no more than one prior chemotherapy regimen.

Pavia, Italy; IRCCS - Policlinico San Matteo, Clinica Malattie dell Apparato Respiratorio
ONCONASE ® plus doxorubicin vs. doxorubicin for patients with Malignant Pleural or Peritoneal Mesothelioma who have had no more than one prior chemotherapy regimen.

Pavia, Italy; IRCCS - Policlinico San Matteo, Divisione di Pneumologia
ONCONASE ® plus doxorubicin vs. doxorubicin for patients with Malignant Pleural or Peritoneal Mesothelioma who have had no more than one prior chemotherapy regimen.

Venezia, Italy; Ospedale Civile di Venezia, Unita Operativa Oncologia Medica
ONCONASE ® plus doxorubicin vs. doxorubicin for patients with Malignant Pleural or Peritoneal Mesothelioma who have had no more than one prior chemotherapy regimen.

Alimta for Mesothelioma

There are many different kinds of mesothelioma treatments that can be used to treat the symptoms of Mesothelioma and to deal with the many effects of this serious illness. And while there is no known cure for mesothelioma yet, there are other methods that can be used to help lengthen the expected lifespan of the person that is afflicted with the disease.

Alimta is a new drug that has been used to help stop the rapid growth of mesothelioma cancerous cells within a patient's body. Alimta was brought out during 2004, and since then it has been helping cancer patients that have Mesothelioma improve and to stop the spread of this deadly disease. It has been shown to successfully help patients live longer and happier lives just by taking Alimta. This particular cancer medication has undergone careful and rigorous scrutiny successfully, that has allowed it to be approved by the FDA.

Alimta Works
Alimta does more than simply work well for Mesothelioma - this drug has also been used to treat other various cancers. It has helped particularly well with lung cancers among others and has pointedly improved the quality of treatment that cancer patients can receive since 2004. Alimta can also be very helpful for anyone who is already taking other medications for mesothelioma since Alimta can be combined with other treatment options.

Not A Cure
While Alimta is not going to completely make your Mesothelioma go away, it will halt the progress of any cancerous cells within your body. This is why Alimta is a perfect to use as a medication because people that have mesothelioma may not have long to live. Once they have been diagnosed with Mesothelioma, most patients with the cancer are not likely to survive very long once the symptoms start to show. Hence, Alimta has been extremely helpful to people who are suffering from Mesothelioma - Alimta helps by halting the progress of the cancer, allowing the patient to live a longer and more fulfilled life than they normally could have.

Alimta And Cispltain
Often, another drug that often goes well with Alimta is Cispltain, which is another form of cancer fighting medication. In many cases, Cisplatin is used in combination with Alimta because these two cancer-fighting agents complement themselves well when working to fight off mesothelioma. This is one situation where two medications can be used together with each other to improve the health of a patient with Mesothelioma.

What Alimta Does
If you are wondering how the new drug Alimta will help you, then you should know that this cancer fighting medication could work for you in helping to destroy cancerous cells. Alimta actually works on the cancer cells themselves, decreasing their ability to grow at their natural rate. This actually provides you with less cancer cells in your body, which will give you a longer life but without this medical assistance you could be left with the 6-12 months that people who are diagnosed with mesothelioma have. Alimta has been tested and proven to help patients who are suffering with mesothelioma and this medication is currently being tested on other cancers to try to stop the growth of other cancerous diseases.

Prepare For Alimta
Your doctor should know several things before treating you with Alimta. It is important that you tell your doctor if you have any previous medical problems. In most cases, they will run you through a rigorous pre-screening process. Your doctor will want to know everything possible about both your full medical history and the medical history of your family before you start any treatment with Alimta.

Talking To Your Doctor
Make sure that you tell the doctor if you are allergic to any medications, even though a doctor should have your full medical chart. There are may be instances when not all allergies that you have are written down and getting this sorted out is important prior to starting the treatment. If the doctor gave a patient a medication that he or she was allergic to, that patient could get sick or even die from this allergic reaction.

It is also a good idea that, prior to taking Alimta, the doctor be well informed of a complete and exhaustive list of each of the medications that you take, how frequently, and how much at a time, including both prescribed and over the counter medications. This will help the doctor make sure that Alimta will not have a bad side effect with another one of your medications that you are currently taking.

Taking Alimta
Alimta is not a simple medication to take. It is far more than just taking a pill with some water. In this particular treatment, specific guidelines must be followed in order to have a successful treatment. Before taking Alimta, it is important to also take two other supplements with this medication, Vitamin B-12 and folic acid. The combination of these two supplements with the medication can create the best possible beneficial situation for the patient. These supplements are taken primarily because there is also a chance of a small skin inflammation after you first start taking the Alimta. Make sure to ask your doctor in which way you could lower the chance of having this outbreak, it is recommended that your doctor should put you on a steroid to lessen the chance of a bad skin reaction when taking Alimta.

Alimta Side Effects
The side effects of any medication are important to be aware. Hence, you should know all of the side effects of any medication prior to deciding to use it as a treatment for your cancer. Most cancer medications have a wide list of side effects, but that is because all of these cancer-destroying medications work on killing the cancerous cells within your body. It is quite frequent that these medications will also damage healthy cells, which is why there is such a chance for side effects. A few of the side effects that Alimta has are loss of hunger, sores inside the mouth, rashes throughout the body, exhaustion, depression, general weakness, and other similar side effects. These may sound bad, however it is much preferred that a patient deal with such minor side effects in order to extend his or her life. The benefits outweigh the risks.

Treatment Options

There are different types of treatment for patients with malignant mesothelioma.

Different types of treatments are available for patients with malignant mesothelioma. The standard treatments are treatments that are currently being used. The other treatment options are being tested in clinical trials. A clinical trial is a research study conducted by doctors and offered to patients with mesothelioma. A clinical trial is meant to help improve the current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the current treatment, the new treatment may become the standard treatment. Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.

Three types of current treatment being used:

1.) Surgery

The following surgical treatments may be used for malignant mesothelioma:

• Wide local excision: This surgery is performed on an area of the body to remove the cancer and some of the healthy tissue around it.

Pleurectomy and decortication: This type of surgery is removal of part of the covering of the lungs, the lining of the chest, and part of the outside surface of the lungs.

Extrapleural pneumonectomy: This surgery is the removal of one whole lung and part of the lining of the chest, the diaphragm, and the lining of the sac around the heart.

Pleurodesis: This is a surgical procedure that uses chemicals or drugs to make a purposeful scar in the space between the layers of the pleura, or the membrane covering the chest cavity. Fluid found in the space is first drained from the space using a catheter or chest tube and the chemical or drug is put into the space. The scarring works by stopping the build-up of fluid in the pleural cavity.

Even if the doctor removes all the cancer that can be seen at the time of the surgery, some patients may be given chemotherapy or radiation therapy after surgery to kill any cancer cells that are left. Treatment given after surgery, to increase the chances of a cure, is called adjuvant therapy.

2.) Radiation therapy

Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. There are two types of radiation therapy. External radiation therapy uses a machine outside the body to send radiation which is aimed or directed toward the area of the cancer inside the body. Internal radiation therapy uses a radioactive substance sealed in needles, seeds, wires, or catheters that are placed directly into the body near the cancer. The type of therapy given, External or Internal radiation therapy, depends on the type and stage of the cancer being treated.

3.) Chemotherapy

Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing or multiplying. When chemotherapy is taken by mouth in pill form or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the entire body (systemic chemotherapy).

When chemotherapy is placed directly into the spinal column, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those specific areas (regional chemotherapy). Combination chemotherapy is the use of more than one anticancer drug. The way the chemotherapy is given depends on the type and stage of the cancer being treated.

New types of treatment and medications are being tested in clinical trials.

Please complete the form below for updated information about clinical trials and new treatments

Mesotheliona Staging

Mesothelioma tend to grow and spread in unusual ways compared to other tumors. Rather than forming a "lump", mesothelioma tends to extent from the pleural lining to press against the lung or abdominal organs. It also grows along the pleural lining, eventually forming a hard casing around the lung and making it difficult for patients to take a deep breath. Mesothelioma generally does not spread widely to other organs but, rather, tends to extensively involve the chest and lungs or abdominal cavity before spreading to other distant organs, late in the course of the disease.

If the disease is detected early, when only limited growth on the pleural lining has occurred (stage I), the tumor is considered potentially curable and an attempt can be made to surgically remove the entire tumor. Usually, however, the tumor is detected later, when it more extensively involves the pleural lining and has possibly invaded surrounding normal structures. In these advanced stages (stages II, III and IV), the cancer significantly impacts the quality of life.

Mesotheliona Symptoms and Diagnosis

Mesothelioma Symptoms
The most common symptoms of pleural mesothelioma are difficulty in breathing, chest pain, or both. Occasionally, a patient may not have mesothelioma symptoms at diagnosis. Other less common symptoms include weight loss, fever, night sweats, cough, and a general feeling of not being well. Mesothelioma symptoms of peritoneal mesothelioma may include swelling, pain due to accumulation of fluid in the abdomen cavity, weight loss, and a mass in the abdomen. Other mesothelioma symptoms of peritoneal mesothelioma may include bowel obstruction, blood clotting abnormalities, anemia (a lowered red blood cell count), and fever.

Mesothelioma Diagnosis
It can be difficult to diagnose mesothelioma because many of the mesothelioma symptoms are similar to those of a number of other conditions, including lung cancer and other types of cancers. At the time of diagnosis, your doctor will first do a physical examination and complete a medical history, including asking about the possibility of prior exposure to asbestos.

Although there is no early detection test for mesothelioma, there are several tests that can be used to help in making the diagnosis of mesothelioma, including a chest x-ray, a CT scan, or an MRI scan. A chest x-ray yields an image of the lungs that will show many types of abnormal changes. A CT scan (computed tomography) is a type of x-ray, but it uses a computer rather than film to create detailed images.

An MRI scan (magnetic resonance imaging) uses magnetism, radio waves, and a computer but does not utilize radiation to create a clear image. These tests help your doctor differentiate mesothelioma from other lung tumors as well as determine where the tumor is and its size.

Your doctor may need to remove a tissue sample from the tumor (a biopsy) or draw fluid (aspirate) from it to confirm it to confirm the diagnosis. This can be done in several ways.

The simplest way to obtain tissue samples involving making a small incision and placing a flexible tube in the area of the tumor. This is called a thoracoscopy if it is done in the chest area. A laparoscopy is the same procedure, but done in the abdominal cavity. A tube that is that is attached to a video camera is placed so that the doctor can look inside the body. A tissue sample may be taken at the same time. Sometimes, however, a more extensive surgical procedure may be advisable. A thoracotomy can be done to open the chest to take a tissue sample and, if feasible, to remove most or all of the visible tumor. If this procedure is done in the abdominal cavity, it is called a laparotomy.

At other times, a mediastinoscopy may be done in which a very small incision is made just above the sternum (breast bone) and a tube inserted just behind the breast bone. This lets the doctors look at lymph nodes. This are small, bean-shaped structures that are an important part of the body's immune system, and they contain cells that help your body fight infection as well as cancer. This test will give the doctor more information on the type of cancer and whether it has spread to other areas. The tissue samples taken in these procedures are analyzed by looking at them under a microscope in order to determine whether the tumor is a mesothelioma or some other type of cancer.

Pleural Mesothelioma


Pleural Mesothelioma / Peritoneal Mesothelioma




The most common place for mesothelioma to develop is in the mesothelial membrane, also called the pleural lining, surrounding the lungs. About two thirds of all mesothelioma cases develop in the pleural mesothelium or lung lining. Pleural mesothelioma is also known as cancer of the lung lining.


The remaining cases, about one third, develop in the peritoneal mesothelium in the abdomen (peritoneal mesothelioma). Rarely, mesothlioma occurs in other mesothelial tissue, such as around the heart or in the reproductive organs (pericardial mesothelioma).

Mesothelioma & lucg cancer

This website was created to provide lung cancer and mesothelioma patients, their families and friends with up-to-date information. The website has four major sections with detailed information on Lung Cancer, Mesothelioma, major Cancer Hospitals and At Risk Jobs.

Lung Cancer
This section explains how cancer develops and other background information about cancer. The effects of smoking with asbestos exposure is detailed in Smoking & Lung Cancer. The Types of Lung Cancer section outlines different categories such as non small cell and small cell lung cancer. The Lung Cancer Symptom section list common lung cancer symptoms that may indicate reason for concern and the need to visit a doctor. Once a diagnosis has been made, a determination of the "stage" or severity of the cancer is made by the doctor. A detailed analysis of the different levels of cancer staging is outlined in Lung Cancer Staging section. Surgery and Chemotherapy, Side Effects and Clinical Trials are all discussed in the Lung Cancer Treatment Options section.

Mesothelioma - Cancer of the Lung Lining
This section provide a descriptions of Pleural Mesothelioma and Peritoneal Mesothelioma. Mesothelioma Symptoms, Diagnosis, Staging and Clinical Trials are also covered. The fact that asbestos causes mesothelioma and the many years it takes to develop mesothelioma cancer are covered in Years to Develop and Asbestos Causes Mesothelioma section.

Cancer Hospitals
It is very important that one obtains the best medical care for your loved one. Divided by state we have listed a number of well known Cancer Hospitals. We hope this provides assistance in finding a location close to your home. It is important that you obtain all the facts about mesothelioma or lung cancer and the best way to treat it. In the Questions & Information From Your Doctor section we have outlined a number of question to consider asking your health care professional.

At Risk Jobs
In our At Risk Job section we have listed a number of asbestos or other hazardous jobs that significantly increase ones chances of obtaining lung cancer or mesothelioma. Individuals who worked in these trades are often eligible for financial assistance.

Malignant Mesothelioma

Malignant mesothelioma is a cancer that affects the lining of the lung, chest cavity, or abdominal cavity. If a tumor formed in the mesothelium—special cells that protect the organs—are cancerous, the disease is called malignant mesothelioma. Malignant mesothelioma is almost always caused by workplace or non-occupational exposure to asbestos.

Who is at risk for malignant mesothelioma?

The most common cause of malignant mesothelioma is asbestos exposure. Workers in the steel, mining, plumbing, milling, insulation, and electric industries, among hundreds of others who handle or manufacture asbestos products, are at the highest risk of developing malignant mesothelioma.

While the risks of the disease increase depending on the frequency and intensity of asbestos exposure, there have been a number of malignant mesothelioma cases among people who have had only one or two months of exposure.

Asbestos fibers are sharp and easily cling to various surfaces such as hair, skin, clothes, and shoes of workers who may track the toxic fibers into their homes subjecting innocent family members to serious illnesses and disease. Family members of those who are regularly exposed to high levels of asbestos also have a high risk of developing malignant mesothelioma.

Types of malignant mesothelioma

There are two primary types of malignant mesothelioma:

  1. Pleural mesothelioma, the most common form of the cancer, grows in the lining covering the lungs.
  2. Peritoneal mesothelioma affects the tissue lining the abdominal cavity.

Mesothelioma is also broken down into cell types, which depend on what the cells look like under a microscope. The cell types include epithelial (50 to 70 percent are diagnosed with this type), sarcomatoid (seven to 20 percent have this type), or mixed (20 to 35 percent have both epithelial and sarcomatoid cells).

symptoms of malignant mesothelioma

Malignant mesothelioma has an extremely long latency period that can take anywhere between 20 to 50 years from the initial exposure to the diagnosis of the disease. Some common mesothelioma symptoms of the malignant type include:

  • chest pains
  • cough
  • shortness of breath
  • severe weight loss

If the disease is discovered early, surgery may be able to remove most of the cancerous tissue. However, malignant mesothelioma spreads rapidly and can affect other organs. During advanced stages of the cancer, mesothelioma chemotherapy treatment and radiation can help to minimize symptoms. Complete recovery may not be possible.

Are you suffering from malignant mesothelioma?

If you or a loved one has been diagnosed with malignant mesothelioma, you don’t have to suffer alone. There are a number of financial, emotional, and medical resources available to you. To learn more, please contact us today.

Mesothelioma Cancer: 12 Essential Facts


Mesothelioma has become a household word to tens of thousands of U.S. citizens. It is a form of cancer associated with asbestos, and with the lawsuits that forced many asbestos companies into bankruptcy. Asbestos was an enormously popular material for construction products and insulation for industrial plants, commercial buildings and homes. By 1985 it was a proven carcinogen, after more than fifty years of suspicion from the medical community and denials from asbestos companies.


( 1 ) The Asbestos – Mesothelioma Link



Unlike most cancer, mesothelioma is almost always caused by just one source: asbestos exposure. The National Cancer Institute says that up to 80% of all mesothelioma cases are caused by asbestos exposure. However additional causes of the disease are just guesses and include such exotic factors as exposure to a mineral in Turkey called Zeolite and previous infection with the Simian monkey virus. Exposure to radiation may make the development of mesothelioma more likely.

For most of the twentieth century, asbestos was heavily used in the manufacture of all types of insulation, flooring, ceiling tiles, pipe fittings, plaster, caulking, roofing, and other construction products. Any industrial facility or power plant (including naval engine rooms) that generated heat probably had pipes, tanks and other fixtures insulated with asbestos. Some sort of asbestos product was at virtually all construction job sites up to 1985 or so.


Asbestos is a fibrous material that when disturbed, emits fibers into the air which can be inhaled by any nearby worker: a miner, a construction worker, a ship’s crewman working around the ship’s pipes and boilers, plumbers, carpenters, auto mechanics, workers in the oil business, in power plants, in chemical plants – the list goes on. The list also includes family members of workers that brought home asbestos fibers on their clothing and shoes from the job site.


(2) Types of Mesothelioma


Mesothelioma is not just lung cancer. It begins in the lining of the chest or abdominal cavities and can impact the organs contained in or near those places: lungs, heart, reproductive organs. The mesothelium is a tissue lining for cavities in the upper body. In the pleural area, the area around the lungs, it is a double tissue with the inner portion (the visceral layer) lining the lungs themselves and the outer portion (the parietal layer) lining the chest wall.

There are three types of mesothelioma: as with the pleural area the disease can impact the lining around the heart and in the abdominal cavity. Mesothelioma is a condition of uncontrolled cell growth that causes the mesothelium layers to thicken and often results in fluid accumulating between the two layers. These cancer cells can be either malignant or benign.


(3) pleural mesothelioma


Pleural mesothelioma impacts the lining of the chest cavity around the lungs. When both the inner and outer membrane layers (the mesothelium) thicken and retain fluid in the area between, pressure is put on the lungs and shortness of breath develops. Other symptoms include a persistent cough, chest pain, hoarseness and perhaps trouble swallowing. The more general symptoms for mesothelioma are fever, weight loss and fatigue, which explains why the initial appearance of mesothelioma symptoms are often misdiagnosed as pneumonia or some other common pulmonary problem.

Pleural mesothelioma is by far the most common form of the disease, accounting for about 75% of all cases. It is, however, a disease of the membranes surrounding the lungs. If the rogue cells are malignant and pass into the lungs, the lung cancer that results is secondary to mesothelioma. Nevertheless, lung cancer that develops as a result of mesothelioma is often referred to as asbestos lung cancer or mesothelioma lung cancer.


(4) Pericardial Mesothelioma


Pericardial mesothelioma impacts the membrane that surrounds the heart. This form of the disease is the rarest: less that 10% mesothelioma diagnoses are for the pericardial variant. One of the issues with pericardial mesothelioma is that medical researchers are unsure how asbestos fibers get into the tissue around the heart. In the case of pleural mesothelioma they are inhaled. How they migrate to the pericardial area is something of a mystery. One theory holds that they break up into smaller pieces after inhalation and somehow are carried to the pericardial area in the bloodstream.

In any case, the impact of asbestos fibers on the pericardial mesothelium is the same as in the pleural area. They cause inflammation which eventually leads to the uncontrolled growth of cells – cancerous cells. As the membrane thickens, fluid buildup occurs and pressure is put on the heart. The symptoms can include an irregular heartbeat and little or no stamina, along with chest pain. Because these characteristics are also symptomatic of heart disease, the diagnosis for mesothelioma is often overlooked initially.


(5) Peritoneal Mesothelioma


This form of the disease impacts the membrane that lines the abdominal cavity, the peritoneum. It is also unclear how this form of the disease develops. The theory for pericardial mesothelioma that tiny asbestos fibers travel through the bloodstream is also applicable for the peritoneal variety. It is also quite possible that asbestos fibers work their way to the abdominal wall through the digestive tract and that they are introduced to the body through eating or drinking.

Asbestos fibers travel through the air like dust and pollen. They could certainly find their way to consumable items on a jobsite. Regardless of the source, the impact of asbestos on the peritoneal membrane is the same. Over time they act as an irritant which results in prolonged inflammation, eventually leading to the development of uncontrolled cancerous cell growth.

Fifteen to twenty percent of all mesothelioma cases are peritoneal. The fact that it is more common than pericardial mesothelioma would suggest that the causal theory based on ingestion makes sense. Lung cancer can also be a secondary development of peritoneal mesothelioma; in addition one of the rare forms of peritoneal mesothelioma can impact the testicles. The membrane within the scrotum is an extension of the peritoneal mesothelium.

Symptoms usually begin with abdominal pain as the fluid buildup caused by the mesothelioma cells begins to impact the abdominal cavity. It can also be accompanied by shortness of breath and a cough, although these symptoms are less common. What peritoneal mesothelioma does share with other types of the disease is a lag of some months between manifestation of the symptoms and a diagnosis.

(6) Years between Asbestos Exposure and

Mesothelioma


Mesothelioma is difficult to diagnose and there are a number of reasons for it. One is that the symptoms mimic those of much more common diseases. Another is that mesothelioma cancer itself does not result in tumor development; that occurs only after the disease has fully developed and metastasized into a nearby organ. But perhaps the most difficult factor is the reality that it takes years and often decades for those asbestos fibers to do their work.

In the case of pleural mesothelioma, the fibers are inhaled and slowly work their way through the lung wall into the mesothelium as the body tries to rid itself of this irritant. Once lodged in the membrane around the lungs, the fibers slowly create a situation where they trigger the development of malformed cancerous cells that begin the process of thickening the membranes which in turn begins the fluid accumulation process.

The result is a remarkably lengthy period of latency for the disease. By the time the symptoms appear – the shortness of breath, fatigue and fever – many years will have elapsed since the asbestos exposure. The patient may be a Navy veteran that spent four years on a ship three decades ago. The asbestos exposure will be long forgotten and the symptoms mirror indications of other more common diseases. The fact that mesothelioma is most often shrouded in a lengthy latency period means that it usually isn’t diagnosed until it has had time to fully develop as a malignant threat.

(7) Developing Mesothelioma Treatment Options


Mesothelioma is not a form of cancer that lends itself to surgical resection. In addition, most diagnoses don’t occur until the disease is in its latter stages. For that reason medical researchers have focused their efforts on extending the period of patient survival after the diagnosis has been made.

These efforts generally focus on slowing or stopping the growth of the cancerous cells. There are a number of approaches to this concept. One chemotherapy drug called cisplatin that is used for mesothelioma treatment has at its core molecules of platinum, which has proven to damage the DNA in certain types of cancer cells, resulting in their inability to reproduce. This sort of targeted chemotherapy does less damage to surrounding healthy cells than some more general formulations of anti-cancer cell agents.

Another chemotherapy drug approved by the FDA for mesothelioma treatment is pemetrexed, a medication that targets enzymes vital to certain types of cancer cells. This is another successful approach to narrowing the focus of chemotherapy and limiting collateral damage; however some mesothelioma cancer cells have shown resistance to pemetrexed.

For that reason, mesothelioma clinical trials have recently been completed that utilize cisplatin and pemetrexed in combination. The result was a significant extension of survival time for many of the participants. Unfortunately, the extension was a period of months rather than years.

(8) Early Diagnosis: the Key to Mesothelioma Survival


Practitioners working on mesothelioma cancer are faced with the difficult combination of a disease that is usually fully developed when diagnosed and that is a diffuse spread of cancer cells that are not gathered in the form of a tumor, often creating a situation where surgery isn’t a viable option. In addition, its initial symptoms are often readily assumed to be the result of some more common problem such as a pulmonary illness or heart problems.

In order to achieve some pattern of early diagnosis, people who know they have been exposed to asbestos must consult with their doctors and seek some preliminary tests to ensure that there are no signs of the disease. CT and MRI scans can today detect thickening of the mesothelium membrane in some cases. If diagnosis can be made before the physical symptoms appear, the doctor may have some chance of bringing growth of the cell mass to a halt before it is too late.

(9) Mesothelioma in the Courts


The toxic nature of asbestos has been evident to some since the 1930s. By 1985 enough people had become sick from asbestos exposure that the relationship between asbestos and mesothelioma was incontrovertibly established. For years, asbestos companies and industrial giants that manufactured products using asbestos denied the health problems associated with it.

By the end of the 1990s the courts had ruled that people who suffered from an asbestos-related disease were entitled to liability compensation from asbestos companies who mined the material and corporations that used it to make consumer and construction products. The result has been several bankruptcies and the establishment of several trusts holding billions of dollars to compensate people who can prove personal damage or damage to a deceased family member as the result of asbestos exposure.

(10) Asbestos is the Cause of Many Illnesses


While the lethal nature of mesothelioma cancer has drawn a lot of the attention given to asbestos toxicity, there are several other afflictions that can be attributed to the material. One of the most common and most harmful is asbestosis. This disease is the result of scarred lung tissue that has been damaged by asbestos fibers. It is a permanent, progressive, restrictive lung illness also known as pulmonary fibrosis. Asbestosis causes shortness of breath, reduced lung capacity and chest pain.

The most common affect of asbestos exposure is pleural plaques. These are smooth, raised strips of fibrous tissue that develop on the pleura. One third to one half of individuals with significant asbestos exposure will develop this condition. They are not pre-malignant and are not believed to lead to further health problems. They will calcify however, and show up on X-rays as an indication of asbestos exposure.

Asthma is also commonly associated with asbestos exposure. Asbestos fibers are a potent pulmonary irritant and are capable of creating the usual reactions to inhaled toxins along with the more serious asbestosis and the lethal development of mesothelioma.

(11 )Mesothelioma Treatment Research


The treatment of mesothelioma is usually palliative in nature. Mesothelioma cancer is not in the form of a tumor that can be removed. Only in the case of pleural mesothelioma is surgery a viable choice, and then only if the disease is still in its earlier stages. In this instance the surgeon will remove some or all of the pleural membranes, possibly with a portion of the chest wall and also possibly a lung.

Even if surgery is an option, usually it is combined with radiation therapy and chemotherapy. In recent years medical researchers have focused their efforts on extending the survival time for patients who have been diagnosed with advanced mesothelioma – by far the most common condition when diagnosis is completed.

The use of targeted chemotherapy is an example of how researchers are approaching mesothelioma today along with a number of other cancer types. Cells that can be programmed to attack or compromise cancer cells and then introduced into the afflicted area have become a common strategy for cancer treatment. Methods of targeting radiotherapy have also been introduced, in order to minimize the destruction of healthy cells adjacent to cancerous cells.

In general, researchers are looking for combinations of radiotherapy and chemotherapy that work best with certain types of mesothelioma cells (there are several) and in certain stages of the disease. Many choices for research are based on patients that have inoperable cases of the disease.

(12) Doctors and Lawyers


Asbestos has affected the health of tens of thousands of people that we are aware of; there is a massive additional population of individuals who were never diagnosed or were exposed and died at a time when asbestos-related industries were in the throes of professional denial.

The courts have slowly come to the realization that this has been a national tragedy of sorts and that there is a large class of people who worked around asbestos, and their families that also suffered as a result, who are entitled to compensation. Asbestos companies have been forced to take financial responsibility to a degree uncommon in product liability law. Today there are trust funds established by these companies that hold billions of dollars to pay for claims against those companies for lives damaged or ruined by asbestos.

There are still many thousands of claims to be filed because of the fact that mesothelioma has such a long latency period. Workers who were exposed to asbestos products on the job site daily during the 1970s may only now be showing the symptoms of asbestos toxicity. If you or a family member may be one of those individuals, it is important to both your health and your financial well being to confirm any potential asbestos health problems with your doctor.

If your physician detects asbestos damage, an attorney with expertise in the field can obtain fiscal damages for you. If you’d like to discuss this possibility, fill out our simple form or give us a call and we’ll put you in touch with an experienced professional who can talk you through the details of your case and go over your options. There will be no financial obligation on your part; that will fall to the asbestos companies if yours is a viable case.